Alan Kazden
CIK: 0001917765
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nexalin Technology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 19, 2025NXL
Nexalin Technology, Inc.
Award(A)DirectStock Option (right to buy)*
100K shares- - Sep 29, 2025NXL
Nexalin Technology, Inc.
Award(A)Indirect36.5K shares- - Nov 2, 2024NXL
Nexalin Technology, Inc.
Purchase(P)DirectStock Option (right to buy)
262.5K shares-
1-3 of 3 transactions
About Kazden Alan
Kazden Alan (SEC CIK 0001917765) files insider reports with the SEC as Director of Nexalin Technology, Inc. (NXL).
Signal8 holds 3 ownership filings by Kazden Alan (2 Form 4, 1 Form 5), filed between Jan 29, 2025 and Dec 23, 2025. Those filings report 3 transactions, from Nov 2, 2024 to Dec 19, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kazden Alan's filings is in CALABASAS, CA.
Recent filings by Kazden Alan
Other insiders filing for Nexalin Technology, Inc. (NXL)
- White Mark, President and CEO
- Van Fleet Justin, CFO
- Owens David, Chief Medical Officer
- Shelton Carolyn Hamby, Senior VP
- Hu Ben, Director
- OSSER LEONARD, 10% Owner